# Etoricoxib

## Arcoxia 60mg

| TAH Drug Code      | [OARC](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OARC)                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Acute & chronic treatment of the signs & symptoms of osteoarthritis (OA) & rheumatoid arthritis (RA); acute gouty arthritis; primary dysmenorrhea.                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | Osteoarthritis: 30mg or 60mg QD Rheumatoid arthritis: 60mg or 90mg QD Ankylosing spondylitis: 60mg or 90mg QD Acute gouty arthritis: 120mg QD, treatment should not exceed 8 days Primary menstrual pain: 120mg QD, treatment should not exceed 8 days Pain relief after dental surgery: 90mg, treatment should not exceed 3 days Pain relief after gynecological surgery: 90mg or 120mg QD, treatment should not exceed 5 days No dose adjustment is required based on age, gender or race. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | CHF (NYHA II-IV), established ischemic heart disease &/or cerebrovascular disease (including those who have recently undergone coronary artery bypass graft surgery or angioplasty). Patient with coronary artery bypass graft (CABG) in 14 days.                                                                                                                                                                                                                                            |
| Adverse Effects    | Asthenia/fatigue, dizziness, lower extremity edema, hypertension, dyspepsia, heartburn, nausea, headache, increased ALT & AST levels. Also, hypersensitivity reactions, dysgeusia, CHF, abdominal pain, peptic ulceration & bleeding, vomiting, angioedema, pruritus, rash, urticaria, renal insufficiency.                                                                                                                                                                                  |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

